APA (7th ed.) Citation

Tolcher, A. W., Rodrigueza, W. V., Rasco, D. W., Patnaik, A., Papadopoulos, K. P., Amaya, A., . . . Messmann, R. A. (2014). A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 73(2), 363-371. https://doi.org/10.1007/s00280-013-2361-0

Chicago Style (17th ed.) Citation

Tolcher, Anthony W., et al. "A Phase 1 Study of the BCL2-targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 in Patients with Advanced Solid Tumors." Cancer Chemotherapy and Pharmacology 73, no. 2 (2014): 363-371. https://doi.org/10.1007/s00280-013-2361-0.

MLA (9th ed.) Citation

Tolcher, Anthony W., et al. "A Phase 1 Study of the BCL2-targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 in Patients with Advanced Solid Tumors." Cancer Chemotherapy and Pharmacology, vol. 73, no. 2, 2014, pp. 363-371, https://doi.org/10.1007/s00280-013-2361-0.